TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Envor Biotech Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
4,462
|
5,407
|
5,972 |
Financial expenses |
159
|
141
|
161 |
Earnings before taxes |
-444
|
-518
|
-2 |
Total assets |
6,969
|
7,403
|
7,921 |
Current assets |
16
|
23
|
36 |
Current liabilities |
5,200
|
4,709
|
4,002 |
Equity capital |
1,457
|
1,635
|
1,644 |
- share capital |
87
![]() |
87
![]() |
87 |
Employees (average) |
6
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
20.9%
|
22.1%
|
20.8% |
Turnover per employee |
901
|
1,194 | |
Profit as a percentage of turnover |
-10.0%
|
-9.6%
|
0.0% |
Return on assets (ROA) |
-4.1%
|
-5.1%
|
2.0% |
Current ratio |
0.3%
|
0.5%
|
0.9% |
Return on equity (ROE) |
-30.5%
|
-31.7%
|
-0.1% |
Change turnover |
-945
|
-565
|
1,602 |
Change turnover % |
-17%
|
-9%
|
37% |
Chg. No. of employees |
1
|
-1 | |
Chg. No. of employees % |
20%
|
-17% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.